Table 1 Patient demographics and baseline laboratory values
Characteristic | Cinacalcet group (n = 33) | Control group (n = 33) | P-value |
|---|---|---|---|
Sex, n (%) | Â | Â | 0.324 |
  Male | 20 (60.6) | 15 (45.5) |  |
  Female | 13 (39.4) | 18 (54.5) |  |
Age, years | Â | Â | 0.520 |
  mean (SD) | 48.8 (11.5) | 47.2 (8.4) |  |
  Range | 25 to 71 | 28 to 64 |  |
Duration of dialysis, months mean (SD) | 78.7 (39.8) | 71.3 (40.6) | 0.454 |
Medical history, n (%) | Â | Â | Â |
  hypertension | 32 (97.0) | 29 (87.9) | 0.355 |
  diabetes mellitus | 7 (21.2) | 5 (15.2) | 0.751 |
  peripheral vascular disease | 2 (6.1) | 0 (0.0) | 0.492 |
  cerebrovascular disease | 2 (6.1) | 0 (0.0) | 0.492 |
  congestive heart failure | 1 (3.0) | 0 (0.0) | 1.000 |
iPTH, median (Q1,Q3) (pg/ml)* | 729 (518, 1424) | 649 (490, 1143) | 0.783 |
Serum calcium, mean (SD) (mg/dL)* | 9.8 (0.6) | 9.6 (0.8) | 0.273 |
Serum phosphorus, mean (SD) (mg/dL)* | 5.8 (1.7) | 5.3 (1.4) | 0.231 |
Ca X P, mean (SD) (mg2/dL2)* | 53.8 (16.3) | 48.7 (14.5) | 0.189 |
Serum FGF23 (Q1,Q3) (RU/ml)* | 3960 (2430, 6609) | 2085 (741, 7182) | 0.134 |
Renal Kt/V (Q1, Q3) | 0.0 (0.0, 0.1) | 0.0 (0.0, 0.5) | 0.170 |
Peritoneal Kt/V (SD) | 1.8 (0.5) | 1.8 (0.6) | 0.956 |
Total Kt/V (SD) | 1.9 (0.4) | 2.1(0.6) | 0.124 |